Answers are grounded in this paper and cite their sources.
In vitro analysis shows cromolyn reduces TRPV1 sensitisation in sensory neurons, suggesting novel analgesic targets.
There is a pressing need for effective alternatives to opioid analgesics, the development of which requires the identification of novel anti-nociceptive drug targets. Here, we have further investigated the anti-nociceptive properties of a GPR35 agonist, cromolyn, in an in vitro model of inflammatory sensitisation. We used ratiometric Ca 2+ imaging of cultured sensory neurons to examine the effect of cromolyn on prostaglandin E 2 (PGE 2 )-mediated sensitisation of the pro-nociceptive ion channel, transient receptor potential cation channel, subfamily V, member 1 (TRPV1). The sensitisation of TRPV1 by PGE 2 was inhibited by cromolyn in a GPR35-dependent manner. These observations provide further evidence in support of an anti-nociceptive role for GPR35, highlighting the potential use of GPR35 agonists as analgesics.
No takes yet. Share an insight, caveat, or question.
Higham et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: